Epilobium angustifolium L. extract with high content in oenothein B on benign prostatic hyperplasia: A monocentric, randomized, double-blind, placebo-controlled clinical trial

Epilobium angustifolium L. extract with high content in oenothein B on benign prostatic hyperplasia: A monocentric, randomized, double-blind, placebo-controlled clinical trial

Benign prostatic hyperplasia (BPH) is a common condition in adult men. Especially in Europe, increasing attention has been focused on E. angustifolium extracts (EAEs), which are widely used for their positive effects on the symptoms of BPH, although human clinical trials are limited. The aim of this...

Full description

Bibliographic Details
Main Authors: Cristina Esposito, Cristina Santarcangelo, Raffaello Masselli, Giuseppe Buonomo, Giovanna Nicotra, Violetta Insolia, Maria D'Avino, Giuseppe Caruso, Antonio Riccardo Buonomo, Roberto Sacchi, Eduardo Sommella, Pietro Campiglia, Gian Carlo Tenore, Maria Daglia
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Benign prostatic hyperplasia
Epilobium angustifolium L. extract
LC-MS metabolic profile
Oenothein B
Randomized double-blind placebo-controlled clinical trial
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221001992

Internet

http://www.sciencedirect.com/science/article/pii/S0753332221001992

Similar Items